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ABSTRACT 
There is an increasing awareness that the inclusion of quality of life as an outcome measure is 
important in ensuring a client-centred and holistic assessment. This review outlines the 
benefits of quality of life as an outcome measurement in the field of prosthetics. It introduces 
the key concepts and challenges in the definition and assessment of quality of life post-
amputation, including the relative advantages and disadvantages of adopting generic, 
disease/condition specific, dimension specific and individualised measures of quality of life. 
In conclusion, the review delineates and recommends issues and guidelines for consideration 
when undertaking quality of life research and assessment. A co-ordinated approach by 
practitioners in the field of prosthetics is necessary to ensure the inclusion of quality of life as 
an outcome measure and to ensure its measurement in a standardised and rigorous manner.  
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INTRODUCTION 
In the field of prosthetics, there is an increasing acknowledgement by practitioners, 
clinicians and therapists of the need to measure the outcomes of their practice 
(Billock, 1996; Hoxie, 1996; Otto, 2003; Polliack & Moser, 1997; Segedy, 2005). 
According to Szabo (2001) the goals of assessing health outcomes are to improve the 
quality of care, the quality of health, and thus ultimately the quality of life (QoL) of 
patients. As the aim of providing people with more effective body functioning is 
central to the fitting of a limb prosthesis most outcomes research is concerned with 
ensuing physical adjustment (e.g. Dudgeon et al., 2005; Pezzin et al., 2000). However, 
function should not be considered in isolation from more general aspects of the 
person’s QoL (Callaghan & Condie, 2003). To concentrate solely on physical 
indicators belies the complexity of the individuals’ amputation experience. Indeed 
Sullivan (2003) states that “the most complete and meaningful assessments of health 
status are now seen to include the perspective of the patient”. Indeed, a burgeoning 
literature evidences the influence of psychosocial variables (e.g. coping, social 
support, body image) on prosthetic rehabilitation and post-amputation adjustment 
(Desmond & MacLachlan, 2006b; Donovan-Hall et al., 2002; Gallagher, 2004; 
Gallagher & MacLachlan, 1999, 2000b, 2001; 2004; Hanley et al., 2004; Horgan & 
MacLachlan, 2004; Jensen et al., 2002). Thus, truly capitalising on the current rate of 
technological development in prosthetics requires attention not only to the physical 
and technical factors which play a fundamental role, but also the social and 
psychological issues facing those ultimately using the technology.  
 
In 1997, Polliack and Moser identified QoL as one of four categories of prosthetic 
outcomes, in addition to clinical/biomechanical evaluation, patient satisfaction, and 
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resource utilisation.  Despite this endorsement and although QoL assessments are now 
widely applied as clinical research outcome measures, QoL assessments are rarely 
implemented in routine clinical practice and there is a notable absence of guidance 
regarding QoL assessment in the field of prosthetics. Indeed, the scope, emphasis, 
suitability and applicability of the variety of instruments used in QoL assessment 
generally, remains controversial (Andresen & Meyers, 2000).  The aims of this review 
are, therefore, to outline a rationale for routine QoL assessment, to introduce key 
concepts in the definition and assessment of QoL post-amputation and to describe a 
variety of issues that should be considered when undertaking QoL research and 
assessment.     
 
BENEFITS OF QOL AS AN OUTCOME MEASUREMENT 
QoL measures are not intended to supplant existing outcome measures associated with 
prosthetic use but rather to supplement them through more holistic assessment of the 
impact of a prosthesis on the individual’s life. Higginson and Carr (2001) outline 
eight potential contributions of QoL measures in routine clinical practice. They can be 
used to identify and prioritise problems and issues of clinical relevance; facilitate 
communication; screen for potential problems as some issues, particularly 
psychological and social issues, can be overlooked unless specifically asked about; 
facilitate shared clinical decision making; identify preferences; monitor changes or 
response to treatment; and train new staff. They can also be used in clinical audit and 
in clinical governance. Additionally, QoL measures are increasingly included in 
clinical trials to demonstrate intervention-related changes over time (Cramer, 2002). 
For example, if two prosthetic interventions result in similar functional benefits, a 
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more favourable QoL impact for one intervention could influence the prescription 
recommendation.  
 
QoL is also important in terms of the recent publication of the World Health 
Organisation’s International Classification of Functioning, Disability and Health 
(ICF) (2001) which emphasises the dynamic intersection of environmental factors and 
individual characteristics in shaping the disability experience. Disability within the 
ICF serves as an umbrella term for impairments, activity limitations and participation 
restrictions. ‘Impairment’ refers to disablement at the organ or system level, for 
example, limb loss (World Health Organization, 2001). According to Heinemann 
(2005) the measurement of activities assesses the degree to which people can 
independently perform daily tasks like walking upstairs, whereas the measurement of 
participation assesses the degree to which individuals are socially integrated, 
productive and involved in the community. QoL is, therefore, considered an outcome 
measure at the participation level in terms of the person’s real life experiences and, as 
such, can highlight potentially negative effects of an intervention (Liddle & 
McKenna, 2000). For example, intervention at an impairment or activity level may 
interfere with participation in life activities due to time in therapy and fatigue. 
Measures at the impairment or activity level may not show such effects, but QoL 
measures have the potential to do so.  
 
DEFINITION OF QOL 
Definition of QoL has proven contentious and despite the proliferation in this field 
there is still no consensual definition or gold standard of measurement. The dominant 
conceptualisation characterises QoL as a multidimensional construct encompassing 
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physical, psychological and social functioning dimensions which are subjectively 
evaluated (Kuijer & de Ridder, 2003). The World Health Organization defines QoL as 
an individual’s perceptions of their position in life, in the context of the culture and 
value systems in which they live and in relation to their goals, expectations, standards 
and concerns. It is a broad ranging concept affected in a complex way by the person’s 
physical health, psychological state, level of independence, social relationships, their 
relationship to the salient features of their environment (WHOQOL Group, 1993, 
1994) and their spiritual, religious and personal beliefs.  
 
Definitional diversity is a major challenge facing QoL research (Rapley, 2003). Most 
definitions acknowledge the multidimensional and subjective nature of QoL, yet 
neither the number nor variety of dimensions are agreed (Rapley, 2003). Lack of 
consensual definition, and indeed the failure of many researchers to make explicit the 
QoL definition to which they subscribe, is a major shortcoming of QoL research.  
Furthermore, the absence of definition renders difficult assessment of the 
appropriateness of QoL measures implemented, reduces comparability between 
studies and consequently limits the development of a robust evidence base.   
 
In health care settings it is argued that it is neither practical nor appropriate to assess 
all that is meant by QoL.  Health related quality of life (HRQoL) concerns aspects of a 
person’s life that are associated with illness, accidents and treatments (Guyatt & 
Jaeschke, 1990). Schipper et al. (1996) describe the four main components of the 
HRQoL construct as (1) physical and occupational functioning, (2) psychological 
state, (3) social interaction and (4) somatic sensations or symptoms.  Although the 
HRQoL construct potentially reduces confounding variables, producing more focused 
   7  
and reliable measurement, HRQoL may provide an artificially and unnecessarily 
narrowed perspective. As illustrated by the exemplar domains above, spiritual and 
economic status are generally not incorporated into HRQoL domains. Yet McGee 
(2004) reports that the ability to earn a reasonable income, financial demands of 
health care itself, and ability to live independently in a safe and healthy environment 
may all be influenced by illness and health interventions and therefore should not be 
excluded.  
 
CHALLENGES IN QOL MEASUREMENT  
Selecting an appropriate measure of QoL 
Generic measures of QoL typically assess multiple health domains and can be used in 
the general population and across different patient populations (Garratt et al., 2002). 
Designed to be applicable across diseases or conditions and treatments or 
interventions, generic measures differ in terms of the number and focus of the 
subscales and items they include (McGee, 2004), see Table 1. A variety of these 
assessments have been used in investigations of QoL among people with amputations 
e.g. the SF-36 (Dougherty, 1999, 2003; Hagberg & Branemark, 2001), the NHP 
(Demet et al., 2002; Demet et al., 2003) and the WHOQOL (Gallagher & 
MacLachlan, 2004).    
 
Disease or condition specific measures of QoL include aspects of health that are 
relevant to particular health problems and may measure several health domains 
(Garratt et al., 2002). These instruments are intended to be sensitive to change in 
aspects of life considered most affected by a condition and its treatment. Within the 
field of prosthetics, condition specific QoL measures include the Prosthesis 
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Evaluation Questionnaire (Legro et al., 1998), Trinity Amputation and Prosthesis 
Experience Scales (TAPES, Gallagher & MacLachlan, 2000a; Gallagher & 
MacLachlan, 2004), the Orthotics and Prosthetics Users' Survey (OPUS, Heinemann 
et al., 2003) and the Questionnaire for Persons with a Transfemoral Amputation (Q-
FTA, Hagberg et al., 2004). Like generic assessments, these instruments differ in their 
development, focus, structure and psychometric properties, see Table 2.   
 
Dimension specific measures focus on a particular component of QoL such as 
psychological well-being, pain, vitality, physical function, and cognitive functioning. 
Arguably, the most widely researched dimensions in the context of amputation are 
physical functioning (e.g. Davidson, 2002; Pohjolainen & Alaranta, 1991), pain (e.g. 
Jensen et al., 2001; Nikolajsen et al., 1997) and affective distress (predominantly 
depression e.g. Desmond & MacLachlan, 2006a; Whyte & Niven, 2001).  Within 
these dimensions numerous different measures have been used with varying results.  
For example, symptoms of depression amongst individuals with amputations have 
been assessed using the Hospital Anxiety and Depression Scale (Zigmond & Snaith, 
1983), the Centre for Epidemiological Studies Depression Scale (Radloff, 1977) and 
the Beck Depression Inventory (Beck et al., 1988; 1961).   
 
Individualised measures of QoL allow respondents to nominate and weight the 
importance of aspects of their own lives thus acknowledging the relative and variable 
nature of QoL across individuals.  Examples, include the Schedule for the Evaluation 
of Individual Quality of Life (SEIQoL) (McGee, 1991; O'Boyle et al., 1992), its 
briefer direct weighting procedure (Hickey et al., 1996), and the Patient Generated 
Index (Ruta et al., 1994). These individualised assessments are based on Calman’s 
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(1984) definition, that is “Quality of life measures the difference, or the gap, at a 
particular period of time, between the hopes and expectations of the individual and the 
individual’s present experiences”. Individualised instruments address the specified 
concerns of the individual patient rather than imposing an external, potentially less 
individually relevant standard through administration of a fixed, predetermined set of 
questions.  
In the SEIQOL, individuals nominate the five aspects of their lives (not necessarily 
health related) which most contribute to their overall QoL at the time of assessment. 
McGee (2004) notes that research has shown that health is not always reported as an 
important aspect of QoL, even in samples with chronic health conditions (Clarke et 
al., 2001), that the SEIQoL is more sensitive to change than generic or illness-related 
measures (O'Boyle et al., 1992) and that QoL, using an individualised measure such 
as the SEIQoL, can remain high in patients in palliative care settings (Waldron et al., 
1999). Unlike the SEIQoL, the PGI (Ruta et al., 1994) was developed to measure 
HRQoL. The PGI acts as an individualised disease-specific outcome measure when 
used with the inclusion of the sentence ‘think of the different areas in your life, or 
activities in your life that have been affected by your condition’, in the instructions. 
The PGI has been used with individuals with lower limb amputations (see Callaghan 
& Condie, 2003, for additional information).    
 
Utility measures were primarily developed for economic purposes and consequently 
are of less relevance in the clinical practice. Their aim is to assess the value of health 
or other interventions in terms of a combination of increased QoL and length of life 
(McGee, 2004).  The assumptions underlying utility measures, as outlined by Koch 
(2000) include the fact that: life quality is based solely on the presence or absence of 
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physical conditions deviating from those of the normal population; future life quality 
does not incorporate the potential role of social values or context but relies only on the 
person’s current physical condition; a person with a physical disability cannot have a 
positive QoL.  Criticisms of oversimplification, inherent discrimination against older 
people and people with disabilities, and the questionable validity of utility measures 
spurred the development of alternative QoL assessments (Liddle & McKenna, 2000). 
 
Generic Vs Condition Specific Measures of QoL 
According to Cella and Nowinski (2002) both generic and condition specific measures 
of QoL play a role in QoL assessment with appropriate choice of measures dependent 
on consideration of the relative advantages and disadvantages of each in the context of 
the purpose of the study. The broad applicability of generic QoL questionnaires allow 
comparisons across different diseases and conditions and across interventions and also 
with ‘healthy’ people. Generic instruments capture a wide range of QoL domains. 
However, in doing so, some of the detail can be lost. Cramer (2002) notes that generic 
instruments are developed for general populations and do not focus specifically on the 
impact of a particular disease or condition, and are thus less likely to detect and 
respond to small but clinically important changes over time or related to interventions. 
Conversely, because of their specificity and the provision of finer and more precise 
detail, condition specific QoL measures cannot include elements of the broader QoL 
picture, are limited to particular groups of people and cannot be used to compare 
groups. The main advantage of condition specific measures is the immediate and overt 
relevance to both people with the condition and clinicians. Clearly generic and 
condition specific measures of QoL are not necessarily mutually exclusive but rather 
can serve to complement each other.  
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Individualised versus Disease Specific Measures of QoL 
A primary challenge in measuring QoL is upholding its subjectivity and uniqueness to 
individuals. Stenner et al. (2003) indicate that the more a researcher emphasises 
subjectivity, together with the fact that this subjectivity is structured by social factors 
such as class, gender, age and cultural identity, the less meaningful generic or 
condition specific measures of QoL become. Carr and Higginson (2001) raise 
questions about the ability of pre-established measures with preselected domains of 
QoL to be truly patient centred and representative of the individual’s QoL. In 
addition, the importance that individuals attach to each domain of QoL will differ 
depending on a myriad of variables including the individual’s expectations and 
aspirations, their own belief system, age, gender, education, environment, marital 
status etc. (Carr & Higginson, 2001). As a result, to truly assess an individual’s QoL, 
it is important that a weighting system is employed. This system of identifying and 
weighting personally relevant domains of QoL increases the likelihood of the measure 
being responsive to change because what is being measured is important in the life of 
the individual (Carr & Higginson, 2001).  
 
Individualised measures also offer an opportunity to study ‘Response shift’ 
(Sprangers & Schwartz, 1999); a phenomenon used to explain how individuals who 
experience periods of continuing difficulty, such as declining health status, fail to 
evidence a reduction in subjective QoL that would be expected by objective standards 
(Carver & Scheier, 2000). The working definition of response shift is a change in the 
meaning of one's self-evaluation of a particular construct (McGee, 2004), in this case 
QoL. Sprangers and Schwartz (1999) propose that response shift can take three forms: 
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a change in the respondents internal standards of measurement (recalibration), a 
change in the respondents values (the relative importance of aspects of the variable 
under consideration), or a redefinition or reconceptualization of the variable (McGee, 
2004).  A combination of these changes may also occur. The use of individualised 
measures advocate and support the notion that disability does not in and of itself result 
in diminished QoL (deLateur, 1997).  Finally, and perhaps most importantly, 
individualised measures appear relevant and clinically meaningful to both clinicians 
and patients and as a result can facilitate shared decision-making and goal and priority 
setting.  For these reasons, increasing emphasis is being placed on individualised 
measures such as the PGI and the SEIQOL.  
 
However, individualised measures are not without limitations. Some people have 
difficulty understanding the system of direct weighting, thus limiting their use as self 
completed questionnaires (e.g. Macduff & Russell, 1998).  Individualised measures 
are also dependent on respondents volunteering domains of QoL important to them. 
However, some domains, e.g. related to mood or sexual functioning, may be less 
likely to be spontaneously volunteered. Additionally, it is assumed that people 
spontaneously identify multiple domains of QoL and track their progress in these 
domains, but there is no evidence base for this assumption.  Wright (2000) also 
highlights the possibility that people may have unrealistic expectations of 
interventions that will need to be accommodated.  Furthermore, the interpretation and 
analysis of data are complex (Carr & Higginson, 2001). Indeed, Dijkers (2003) 
identifies the main disadvantage of individualised measures as burden both on the 
respondent and administrator.  
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ASSESSING QOL MEASURES 
QoL is a complex, abstract, and multidimensional concept that is difficult to define 
and perhaps even more difficult to measure (Rapley, 2003). However, the apparent 
elusiveness of the QoL concept should not detract from its importance or prevent 
standardised and rigorous measurement.  In this concluding section we offer some 
guidelines for consideration when undertaking QoL assessment.   
 
At the outset a clear statement of the definition of QoL underpinning the research, 
should be provided. This definition together with information on the sample, 
outcomes of interest and research aims (e.g. clinical trial, evaluating change in groups 
with a specific disease or condition etc.) should influence the selection of an 
appropriate QoL measure(s) assessing domains pertinent to the definition adopted, the 
sample being researched and the research question. The choice of an appropriate QoL 
instrument also depends on the characteristics of the target audience (e.g. age, 
cognitive ability, culture, language etc.) and the setting in which assessment will take 
place (e.g. private or open area, noise etc.).  Instrument selection should be informed 
by comprehensive review of literature and research in the field to identify existing 
measures appropriately and successfully used previously for similar purposes. 
Candidate measures should be reviewed in light of the above criteria, but also in terms 
of their psychometric properties.  Psychometric properties essential for QoL measures 
in clinical practice include the instruments validity, reliability, responsiveness and 
interpretability. (For a review of these psychometric properties, see (Scientific 
Advisory Committee of the Medical Outcomes Trust, 2002;  Arguably, a more co-
ordinated effort needs to take place to establish and review the psychometric 
properties of QoL instruments to be used with people wearing prosthetics. 
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Meyers and Andresen (2000) highlight the importance of reviewing the time reference 
period assessed in the instrument. Standard research instruments typically incorporate 
items requiring respondents to make general statements about their health in the “past 
six months”, or “past 4 weeks”, or even “past 3-6 days” (Meyers & Andresen, 2000).  
While such questions may be meaningful to most respondents, they are arguably less 
meaningful for those who experience dramatic health status changes over short time 
periods e.g. relapsing remitting MS or Parkinson’s disease.  In addition, such 
questions are problematic as they fail to account for the short-term memory loss or 
distortion experienced by individuals with TBIs, strokes or mental illness (Meyers & 
Andresen, 2000).   Consideration of the time reference periods and the implications 
for those who experience unstable conditions is a critical element in selecting 
appropriate assessments. Fitzpatrick (2000) contends that a primary impediment to the 
use of QoL measures in clinical practice is the lack of intuitive meaning and 
familiarity provided by the scores derived.  For instance, at what point does a problem 
become severe or what constitutes a meaningful change in QoL scores before and 
after an intervention? Consequently, when reviewing QoL measures investigate 
whether data is presented in useful forms that can be incorporated into practice. 
Finally, the burden, that is, the time, effort and others demands that the QoL measure 
may impose should be seriously considered (Scientific Advisory Committee of the 
Medical Outcomes Trust, 2002).   
 
CONCLUSION 
Incorporating the patient’s perspective is a central component in rehabilitation and 
assessing QoL is an important aspect of this endeavour. Consideration of the relative 
   15  
advantages and disadvantages of the available QoL measurement options best drives 
choice of instrument (Cella & Nowinski, 2002). A combination of measures may also 
be appropriate. Overall, a co-ordinated approach by practitioners in the field of 
prosthetics is necessary to ensure the inclusion of QoL as an outcome measure and to 
ensure its measurement in a standardised and rigorous manner.  
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Table 1: Generic quality of life assessments  
Instrument Dimensions included  
Medical Outcome Study Short Form 36 (SF-
36) 
Social functioning  
Role functioning 
Mental health  
Energy-vitality  
Pain  
General health  
Physical health 
Nottingham Health Profile  Emotional reactions  
Energy level 
Pain  
Physical mobility  
Sleep  
Social interaction 
World Health Organization Quality of Life 
Questionnaire (Brief Version) (WHOQOL-
BREF) 
Physical health 
Psychological 
Social Relationships  
Environment 
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Table 2: Amputation specific instruments 
 
Instrument Dimensions included 
Trinity Amputation and 
Prosthesis Experience Scales 
Psychosocial Adjustment:  
General Adjustment 
Social Adjustment 
Adjustment to Limitation 
Activity Restriction: 
Functional  
Social  
Athletic  
Prosthesis Satisfaction  
Weight  
Functional  
Aesthetic  
Pain and other medical problems  
Prosthesis Evaluation 
Questionnaire  
Ambulation 
Appearance 
Frustration 
Perceived response 
Residual limb health 
Social burden 
Sounds 
Utility 
Well being 
Other 
Orthotics and Prosthetics 
Users' Survey 
Functional status 
Quality of life  
Satisfaction with devices and services 
Questionnaire for Persons with 
a Transfemoral Amputation 
Use 
Mobility 
Problems 
Global health 
